First Time Loading...

Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 0.7399 USD 0.64%
Updated: May 3, 2024

Chemomab Therapeutics Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemomab Therapeutics Ltd
Cash from Financing Activities Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Cash from Financing Activities
$3.5m
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash from Financing Activities
$1.1m
CAGR 3-Years
-37%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Cash from Financing Activities
$22.7m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
-7%
Urogen Pharma Ltd
NASDAQ:URGN
Cash from Financing Activities
$116.9m
CAGR 3-Years
92%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash from Financing Activities
$6m
CAGR 3-Years
14%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cash from Financing Activities
-₪1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Chemomab Therapeutics Ltd's Cash from Financing Activities?
Cash from Financing Activities
3.5m USD

Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Cash from Financing Activities amounts to 3.5m USD.

What is Chemomab Therapeutics Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-10%

The average annual Cash from Financing Activities growth rates for Chemomab Therapeutics Ltd have been -10% over the past three years .